蛋白质SUMO化修饰与肿瘤调控

SUMO化修饰是一种重要的蛋白质翻译后修饰方式,在细胞周期调控、细胞代谢、基因转录、DNA损伤和修复等众多细胞生物学过程中,对底物蛋白质的表达、定位和活性进行调控。蛋白质SUMO化修饰是动态可逆的过程,去SUMO化修饰由SUMO特异性蛋白酶(SENPs)家族成员所催化。由于受到SUMO化修饰的底物蛋白种类众多、功能多样,SUMO化修饰能够在整体和特定蛋白质修饰层面,参与调控肿瘤的发生发展,并且这种调控机制非常复杂,比如调控细胞周期的进程、DNA损伤和基因组不稳定性、肿瘤代谢与生长、抗肿瘤免疫等。SENPs家族成员是底物蛋白质SUMO化修饰程度的决定者,该研究团队对SENPs家族成员在肿瘤中的作用开展了系列研究,因此该文也将以SENP1和SENP3为例,对SENPs在肿瘤进程中的作用及其作用机制展开介绍。     

内质网未折叠蛋白应答

<正>生命每时每刻都在制造蛋白质,大部分蛋白质需要经过翻译后修饰并进一步折叠出正确空间结构后被运输到特定位置发挥正确生物学功能。然而细胞在营养缺乏、病毒感染等不利环境下,容易导致蛋白质修饰异常而破坏蛋白质折叠,造成大量未折叠蛋白质积累而损伤细胞功能。为此,细胞需通过三方面调整来适应环境,包括减少翻译以缓解新生蛋白的折叠需求;降解未折叠蛋白质以减轻损伤;增加细胞伴侣蛋白表达以协助蛋白质折叠,这个过     

去泛素化酶活性的调控

泛素化是一种非常重要的蛋白质翻译后修饰方式,在细胞生命活动的各个方面发挥作用。泛素化修饰是可逆的过程,去泛素化酶通过催化去除底物蛋白质上的泛素从而逆转该过程。去泛素化酶是一类数量众多的蛋白水解酶家族,近年来不断有新的去泛素化酶被发现和报道。鉴于其在细胞功能中的重要作用,去泛素化酶活性受到严格的调控。目前的研究表明,影响去泛素化酶活性的因素很多。本文主要从转录水平的调控、翻译后修饰、蛋白质定位和蛋白质相互作用等调控方式进行论述,以期为研究和利用去泛素化酶治疗疾病提供新思路。     

乙酰化修饰对人非组蛋白稳定性调控功能的最新进展

乙酰化修饰是一种广泛存在于生物体中的可逆性蛋白质翻译后修饰方式,主要发生于蛋白质赖氨酸残基的侧链NH2基团上,最早在组蛋白中发现。乙酰化修饰主要通过修饰组蛋白影响细胞的染色质结构以及激活细胞核内转录因子,从基因组水平来调控细胞的生命活动。随着乙酰化修饰检测技术和生物学研究的发展,发现乙酰化修饰也大量存在于非组蛋白中,并调控蛋白质的功能,进而影响多种生物学过程。其中,乙酰化修饰可以调控非组蛋白的稳定性,使其在细胞中更加稳定和持久地存在,这种调控机制在细胞的生长和分化等过程中具有重要作用,并影响多种疾病的发生发展。该文介绍了乙酰化修饰及其主要的生物学功能,系统总结了乙酰化修饰对人非组蛋白稳定性调控的机制与功能的影响,并介绍了乙酰化修饰调控蛋白质稳定性对疾病发生发展的作用,有助于解析疾病的发生机制,为疾病的治疗提供新的思路和方法。     

蛋白质乙酰化修饰在细胞自噬中的作用进展

蛋白质翻译后修饰与细胞自噬的关系是近几年来的研究热点.自噬的发生需要多类蛋白质协同完成.在此过程中,蛋白质的乙酰化修饰对细胞自噬起着十分重要的调节作用.本文就近年来的研究从两个角度进行了总结:一方面总结了蛋白质乙酰化修饰与自噬关系的功能性研究,主要涉及组蛋白、转录因子以及与乙酰辅酶A代谢过程中相关酶的研究进展;另一方面概括了细胞自噬过程中蛋白质乙酰化修饰组学的研究进展.乙酰化酶/去乙酰化酶是蛋白质乙酰化修饰水平的主要调控者,阐明酶与底物的关系将是深入探讨乙酰化修饰与细胞自噬关系的关键所在.这些研究结果必将为揭开细胞自噬机制提供理论基础.     

蛋白质的棕榈酰化修饰

棕榈酰化修饰是蛋白质翻译后脂质修饰的重要形式,是调控蛋白质的转运、稳定、定位和功能的重要机制,同时,棕榈酰化修饰还参与多种细胞生物学进程,与许多疾病的发生发展密切相关。本文主要就蛋白质棕榈酰化及其修饰酶与蛋白质功能、相关疾病的关系做一综述。     

蛋白质组中蛋白质磷酸化研究进展

随着后基因组时代的到来 ,对生命体器官、组织或细胞的全部蛋白质的表达、修饰及相互作用的研究已成为蛋白质组学的重要任务。蛋白质磷酸化是细胞内信号转导和酶调控最常见的机制之一 ,人类基因组约 2 %的基因编码 5 0 0种激酶和 10 0种磷酸酶。蛋白质磷酸化和去磷酸化作为原核和真核细胞表达调控的关键环节 ,了解其对功能的影响可以深入理解生命系统在分子水平的调控状况。目前蛋白质组磷酸化研究仍是功能基因组面临的重大课题 ,本文对此作一综述     

基于质谱的蛋白质组学信号网络研究进展

细胞信号转导网络调控着所有细胞和器官的生物学过程。以往信号转导网络的研究主要采用一些生物化学方法开展,如抗体技术。目前,基于质谱的大规模蛋白质组学研究可以在翻译后修饰、蛋白质互作及蛋白质表达水平上,系统地研究信号转导事件。基于蛋白质组学的大规模信号转导的研究将改变我们对信号转导网络的理解。从蛋白质组翻译后修饰、蛋白质互作及蛋白质表达3个方面综述了质谱在信号转导方面的研究。     

精子发生过程中蛋白质翻译后修饰的研究进展

精子发生是一个高度复杂且受到精密调控的生物学过程,其中蛋白质作为生命活动的最终执行者,其翻译后修饰发挥着重要的调控作用。精子发生过程中存在多种蛋白质翻译后修饰,如磷酸化、乙酰化、泛素化等,其异常可引起精子发生障碍,严重的甚至可导致不育。随着蛋白质组学技术的快速发展,基于临床不育样本和模式动物的功能研究,可以系统性解析精子发生过程中蛋白质翻译后修饰的动态调节与功能,揭示精子发生的分子调控机制以及男性不育的发病机理。该文就近年来精子发生过程中蛋白质翻译后修饰调控机制,以及少精子症、弱精子症和畸形精子症等临床疾病中蛋白质翻译后修饰的研究进展进行了综述。     

端粒酶调控机制的研究进展

端粒酶在细胞中的主要生物学功能是通过其逆转录酶活性复制和延长端粒DNA来稳定染色体端粒DNA的长度。近年有关端粒酶与肿瘤关系的研究进展表明,在肿瘤细胞中端粒酶还参与了对肿瘤细胞的凋亡和基因组稳定的调控过程。与端粒酶的多重生物学活性相对应,肿瘤细胞中也存在复杂的端粒酶调控网络。通过蛋白质-蛋白质相互作用在翻译后水平对端粒酶活性及功能进行调控,则是目前研究端粒酶调控机制的热点之一。     

Enzymology and significance of protein histidine methylation

Cells synthesize proteins using 20 standard amino acids and expand their biochemical repertoire through intricate enzyme-mediated post-translational modifications (PTMs). PTMs can either be static and represent protein editing events or be dynamically regulated as a part of a cellular response to specific stimuli. Protein histidine methylation (Hme) was an elusive PTM for over 5 decades and has only recently attracted considerable attention through discoveries concerning its enzymology, extent, and function. Here, we review the status of the Hme field and discuss the implications of Hme in physiological and cellular processes. We also review the experimental toolbox for analysis of Hme and discuss the strengths and weaknesses of different experimental approaches. The findings discussed in this review demonstrate that Hme is widespread across cells and tissues and functionally regulates key cellular processes such as cytoskeletal dynamics and protein translation. Collectively, the findings discussed here showcase Hme as a regulator of key cellular functions and highlight the regulation of this modification as an emerging field of biological research.     

Dual Coordination of Post Translational Modifications in Human Protein Networks

Post-translational modifications (PTMs) regulate protein activity, stability and interaction profiles and are critical for cellular functioning. Further regulation is gained through PTM interplay whereby modifications modulate the occurrence of other PTMs or act in combination. Integration of global acetylation, ubiquitination and tyrosine or serine/threonine phosphorylation datasets with protein interaction data identified hundreds of protein complexes that selectively accumulate each PTM, indicating coordinated targeting of specific molecular functions. A second layer of PTM coordination exists in these complexes, mediated by PTM integration (PTMi) spots. PTMi spots represent very dense modification patterns in disordered protein regions and showed an equally high mutation rate as functional protein domains in cancer, inferring equivocal importance for cellular functioning. Systematic PTMi spot identification highlighted more than 300 candidate proteins for combinatorial PTM regulation. This study reveals two global PTM coordination mechanisms and emphasizes dataset integration as requisite in proteomic PTM studies to better predict modification impact on cellular signaling.     

细菌体内乙酰化修饰研究进展

翻译后修饰是指前体蛋白经过一系列加工修饰形成具有多种功能的蛋白质,其可以发生在不同的氨基酸侧链或肽键上,通常是由酶活性介导的.5％的蛋白质组组成的酶介导了超过200多种的翻译后修饰类型,其中乙酰化修饰是一种重要的翻译后修饰途径.乙酰化修饰在真核细胞中被广泛研究,其几乎参与细胞的所有生理活动并且高度保守.最近的很多研究表...     

The Plant PTM Viewer,a central resource for exploring plant protein modifications

Post‐translational modifications (PTMs) of proteins are central in any kind of cellular signaling. Modern mass spectrometry technologies enable comprehensive identification and quantification of various PTMs. Given the increased numbers and types of mapped protein modifications, a database is necessary that simultaneously integrates and compares site‐specific information for different PTMs, especially in plants for which the available PTM data are poorly catalogued. Here, we present the Plant PTM Viewer (http://www.psb.ugent.be/PlantPTMViewer), an integrative PTM resource that comprises approximately 370 000 PTM sites for 19 types of protein modifications in plant proteins from five different species. The Plant PTM Viewer provides the user with a protein sequence overview in which the experimentally evidenced PTMs are highlighted together with an estimate of the confidence by which the modified peptides and, if possible, the actual modification sites were identified and with functional protein domains or active site residues. The PTM sequence search tool can query PTM combinations in specific protein sequences, whereas the PTM BLAST tool searches for modified protein sequences to detect conserved PTMs in homologous sequences. Taken together, these tools help to assume the role and potential interplay of PTMs in specific proteins or within a broader systems biology context. The Plant PTM Viewer is an open repository that allows the submission of mass spectrometry‐based PTM data to remain at pace with future PTM plant studies.     

Site-selective glycosylation of proteins: creating synthetic glycoproteins

In higher organisms, the functions of many proteins are modulated by post-translational modifications (PTMs). Glycosylation is by far the most diverse of the PTM processes. Natural protein production methods typically produce PTM or glycoform mixtures within which function is difficult to dissect or control. Chemical tagging methods allow the precise attachment of multiple glycosylation modifications to bacterially expressed (bare) protein scaffolds, allowing reconstitution of functionally effective mimics of glycoproteins in higher organisms. In this way combining chemical control of PTM with readily available protein scaffolds provides a systematic platform for creating probes of protein-PTM interactions. This protocol describes the modification of Cys residues in proteins using glycomethanethiosulfonates and glycoselenenylsulfides and the modification of azidohomoalanine residues, introduced by Met replacement using auxotrophic Met(-) Escherichia coli strains, with glycoalkynes and the combination of these techniques for the creation of dual-tagged proteins. Each glycosylation procedure outlined in this protocol can be achieved in half a day.     

Post-translational modification of plant-made foreign proteins; glycosylation and beyond

The complex and diverse nature of the post-translational modification (PTM) of proteins represents an efficient and cost-effective mechanism for the exponential diversification of the genome. PTMs have been shown to affect almost every aspect of protein activity, including function, localisation, stability, and dynamic interactions with other molecules. Although many PTMs are evolutionarily conserved there are also important kingdom-specific modifications which should be considered when expressing recombinant proteins. Plants are gaining increasing acceptance as an expression system for recombinant proteins, particularly where eukaryotic-like PTMs are required. Glycosylation is the most extensively studied PTM of plant-made recombinant proteins. However, other types of protein processing and modification also occur which are important for the production of high quality recombinant protein, such as hydroxylation and lipidation. Plant and/or protein engineering approaches offer many opportunities to exploit PTM pathways allowing the molecular farmer to produce a humanised product with modifications functionally similar or identical to the native protein. Indeed, plants have demonstrated a high degree of tolerance to changes in PTM pathways allowing recombinant proteins to be modified in a specific and controlled manner, frequently resulting in a homogeneity of product which is currently unrivalled by alternative expression platforms. Whether a recombinant protein is intended for use as a scientific reagent, a cosmetic additive or as a pharmaceutical, PTMs through their presence and complexity, offer an extensive range of options for the rational design of humanised (biosimilar), enhanced (biobetter) or novel products.     

Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers

Colorectal cancer (CRC) is one of the costliest health problems and ranks second in cancer-related mortality in developed countries. With the aid of proteomics, many protein biomarkers for the diagnosis, prognosis, and precise management of CRC have been identified. Furthermore, some protein biomarkers exhibit structural diversity after modifications. Post-translational modifications (PTMs), most of which are catalyzed by a variety of enzymes, extensively increase protein diversity and are involved in many complex and dynamic cellular processes through the regulation of protein function. Accumulating evidence suggests that abnormal PTM events are associated with a variety of human diseases, such as CRC, thus highlighting the need for studying PTMs to discover both the molecular mechanisms and therapeutic targets of CRC. In this review, we begin with a brief overview of the importance of protein PTMs, discuss the general strategies for proteomic profiling of several key PTMs (including phosphorylation, acetylation, glycosylation, ubiquitination, methylation, and citrullination), shift the emphasis to describing the specific methods used for delineating the global landscapes of each of these PTMs, and summarize the recent applications of these methods to explore the potential roles of the PTMs in CRC. Finally, we discuss the current status of PTM research on CRC and provide future perspectives on how PTM regulation can play an essential role in translational medicine for early diagnosis, prognosis stratification, and therapeutic intervention in CRC.     

Post-translational modifications of the polycystin proteins

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of kidney failure and affects up to 12 million people worldwide. Germline mutations in two genes, PKD1 or PKD2, account for almost all patients with ADPKD. The ADPKD proteins, polycystin-1 (PC1) and polycystin-2 (PC2), are regulated by post-translational modifications (PTM), with phosphorylation, glycosylation and proteolytic cleavage being the best described changes. A few PTMs have been shown to regulate polycystin trafficking, signalling, localisation or stability and thus their physiological function. A key challenge for the future will be to elucidate the functional significance of all the individual PTMs reported to date. Finally, it is possible that site-specific mutations that disrupt PTM could contribute to cystogenesis although in the majority of cases, confirmatory evidence is awaited.